Converge Bio is building the lab of the future: a computational lab powered by generative AI for biotech and pharma across R&D and into clinical trials. Delivered as a SaaS subscription, the Converge Computational Lab provides a private, configurable instance with solutions for antibody design, protein expression optimization, virtual cell simulation, target discovery, drug repurposing, patient stratification, and CMC process optimization. Converge Bio is AI first by design, uniting computational biologists and machine learning experts to build state-of-the-art models for every step of biological R&D.